ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000225.1|Frenolicin_1 # 1 # 423 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.726	BGC0000225.1|Frenolicin_1 	1	423	-	Loose	450	24.2534	rmtG	32.69	3002668	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGAGACGTCTTCGTGCCCTCTTGTGCGGCGCCGCCGCCTCCGCGCTCGCCGCCGCCGGGCTCACCGCGCTGCTGCCCGCCTCGGCCTCCGGCGCCGAGAGCGCGACGCTGGACAAGCGGTGGTACGCCGCCGCGCCCTACCTCATGCCGCTCGACAACGACCCGCCCAGCGCCACCGCGATCAGCCGCAACTGGTACGCCTCGTCGTCGACGTCCGTGACCTCCGCGCCCTCCTCCAGCGGCTCCGCGAGGAAGAACGCGCCGTGCTGCGCGGTCACGACCGGCGTCAGCTCGCTCATGATGAGCTGCGCGACGTCCACGAGGTCGCGGCGGCCCTGGAGCAGCCCGGAGATACGCGCCAGGTTGCCCTTGAGCCAGCTCTGCTCCTCGTTGGCGAGCGTCGTGTCCCGCAGGTTGCCGATC	MRRLRALLCGAAASALAAAGLTALLPASASGAESATLDKRWYAAAPYLMPLDNDPPSATAISRNWYASSSTSVTSAPSSSGSARKNAPCCAVTTGVSSLMMSCATSTRSRRPWSSPEIRARLPLSQLCSSLASVVSRRLPI	MRDPLFEKLAASKKYRDVCPDTIARILTECRAKYRREKEIDKAAREKLHGITAAFMTDAEYRRAMEIAVRGGELAELMECHASTRERLPLEETDAVYARLLGAPDESALDLACGLNPAYLQNRYPEMRVTGIDISGQCVRVLRALGVDARLGDLLAENAIPRARYSVALLFKILPLLDRQSAGAARRILEAVNADALICSFPTRSLSGRNVGMAVHYAAWMRDQLPEKWRIERTVETDNELYYVLKEKQDGEAVRGGDSHRESE	53.41	gnl|BL_ORD_ID|1266|hsp_num:0	1382			147	300	amikacin; tobramycin; arbekacin; gentamicin A; gentamicin
BGC0000225.1|Frenolicin_3 # 879 # 1010 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.568	BGC0000225.1|Frenolicin_3 	879	1010	+	Loose	700	21.557	vanS gene in vanL cluster	40.0	3002938	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGGCCCCGCCAAGTAAAGGAATGACCGTCCGGAGTTCAATCACTTCCACAATTGCCATGGAATGCCCGGTTATAAGGGAAGTGGAATGTGTCACCGCCGTCGTCGCGTGGGGCGGTGGGCGGCTAATGTGA	MAPPSKGMTVRSSITSTIAMECPVIREVECVTAVVAWGGGRLM	MKSKAETTTIKQILIKYLVTIGLSMLAYLVFLLTILIIMRNFVWDGTEPIYRVLHFFYRLFNFEGILIIGVILILFVVTLFFVMKIIGYLKQIIEATKQLLEKPEQRVKLSSGLFELQEEMNQLREKNNADNRAAKEAEKRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPEISVQTRAKYTNIALSKAFRLEELLSEFFDVTRFNLTNLTINEELVDLSVMLEQISYEFLPILEEKKLSWNLHVESNIKSLLDPGKMERVFDNLMRNAINYSFEDTIIDLSLEKKESQAIFKITNRTYTIPKEKLEKIFEPFYRMDTSRSSSTGGTGLGLPIVREIIEASKGTINVSSSNNEMTFIIYLPYID	11.81	gnl|BL_ORD_ID|4734|hsp_num:0	744			951	1011	vancomycin
BGC0000225.1|Frenolicin_5 # 1563 # 3875 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000225.1|Frenolicin_5 	1563	3875	+	Loose	560	30.8018	OXA-269	26.21	3001725	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGCCGGCAGCGGCTACGCGTACTACCAGCACCTCAGCGGCAACATCGACAAGATTGACGTCGGCGACGCGGGCAACAAGGACGCCGCCCCCGACGGGCCGATCAACATCCTGATCATCGGCACCGACAAGCGCACCGGCAAGGGCAACGAGGGGTGCGGGGGCAAGGACAGCCCTGGCCACGCGGACACCAACATCTTGCTGCGCGTCTCCGCCGACCGCACCAACACGACCGGCCTGAGCATTCCGCGTGACCTCATCACGAACATCCCGGACTGCCTGACCACCCAGGACGACGGTTCGAAGAAGACGATCCCCGGCACGCAGAACGTCCGCTTCAACACGAGCCTCGGGCAGGAGGGCCGCGACCCCGGCTGCACGATGCGCACGGTCACCGAGCTGACCGGGCTCAAGGTCGACCACTTCATGATGGCCGACTTCAACGCGGTCAAGAACCTGACGACGGCCGTGAACGGCGTCGAGGTGTGCGTGGCGAAGGACGTCGACGACCCCGACTCGCACCTCAAGCTCTCGGCGGGGACGCACAAGGTGCAGGGCGAGCAGGCGCTCGCCTTCGTCCGCACCCGGCACAGCTTCGGCAACCAGGGCGACCTCGACCGCATCAAGGTCCAGCAGCAGTTCCTCGGTTCGCTCGCGCGGCAGCTCAAGTCCGAGGACACGCTGACGAGTCCGAAGAAGCTCTACAAGGTCGCCGAGGCGGCGACCGACGCGCTGACCGTGGACTCGGGGATCGGCAGCATCACGAAACTGATGTCGCTGGCCAAGGAGTTGCAGCACATCAATCCGAAGAACATCACCTTCGTGACGCTCCCCGTGGTCGACAACCCGGCCGAGAAGGTCAAGGCGACGGTCGTCCTCAATGAGACGGACGCTGATCCGCAGCAGTCGGCTCTCGGGCAGAGTCTCGACGTGGGCCGCCAGCTCGTCGACTCGCTCACCGACCAGGACCCGCGCGACGGCAAGACCGTCCCGTGGCTCGCGACGCGCTGGAAGGCCGACCCCGAGGCCACCCGCTTCACCTTCACCCTGCGCGCGGGCGCCACTTTCAGCGACGGCACACCGGTCGACGCGCGCGCGGTCAAGGCCAACTTCGACGCCGTGCACGAGCTCGGCGCCGCCGCCTCGCGGGGGGCCGTGTACCTCGACGGCTACCGCGAGACGCGCGTCAGCGGCGCCCGTACGCTCACGGTCGTCTTCGACAAGCCGAACGCCCAGTTCCTGCGCGGCACGTCCACCGTCTCACTGGGCCTGCTCTCGCCGGGCAGCCTGCGCCGCACCCCGCAGGAGCGCTGCACCGGGCGCCTCGTCGGCTCCGGTCCCTTCGTGCTCGACCGCTACCGGCCGAACACCTCCGTCACGCTGGACCGGAGAAAGGGCTACTCCTGGGGCTCGCGCCTGTGGCAACGGGAGGGCGGCGCGTACCTGGAGGGGGTCGAGTACCGGATCGTGCCCGAGAACACGACCCGCTCGGGCGCCCTGTCCGCCGGTCAGCTCGACGTCGCCACCGCGCTCGCGCCGCAGGACAGGGAGCGGTTCTCCGCCCCCGGCTGGTCGCTGCTGACCCGTACCGCGCCCGGCGTCGACCTCAGCCTGTACGTCAACGCGCGCCGCACGGCGCTGCGCGAGGCGGCGGTGCGCCAGGCCCTCCAGAAGGGCATCGACCGCGAAGCCGTCGCCACGACCTTCCTCAGTTCCCGCAAGCTCGCGGCGACCAGCGTGCTCTCCTCCACGACCCCCGGCTACACCGACCTCGGCGACCGCCTCGCCCACGACCCTGCGGGTGCGAGGCGGCTGCTCGACAAGGCCGGATGGCGGCCCGGGGCGGACGGCATCAGGGTCAAGAACGGCGTCAGGCTGCGACTCGACGCCGTCTTCGTCCGGCAGCAGAGCCTCGAACTCGTGCAGCAGCAGCTCAAGGACATCGGCGTCGAACTGCGGCTGAGACAGCTCACCGTCTCCCGTTTCCCCGAAGTGCTCGCCGCGGGCAGCTACGACCTGAGCCTCCAGAGCGCCAACCGCGCCGATCCCGACGTCCTCACCACGGCCTTCGCGGGCGGCACCCCCGTCGCCGACGCGCGCCTGCGCTCCGAACTGCGCCGGGCCACCTCCTCCACCGACGAGGCGACGCGCTCCTCGCTCTTCGCCGCGGCGCAACGGCGTCTCGTCGACGAGGGGCACGTCCTGCCGCTCAACGAGACCGAGGAGACCGCCGCGCTCTCGACGCGGGTGCACGGGCTGACGCGGGACGCCTCCAACCGGCTGGTCCTGCACGACACCTGGACCACCGGGTGA	MAGSGYAYYQHLSGNIDKIDVGDAGNKDAAPDGPINILIIGTDKRTGKGNEGCGGKDSPGHADTNILLRVSADRTNTTGLSIPRDLITNIPDCLTTQDDGSKKTIPGTQNVRFNTSLGQEGRDPGCTMRTVTELTGLKVDHFMMADFNAVKNLTTAVNGVEVCVAKDVDDPDSHLKLSAGTHKVQGEQALAFVRTRHSFGNQGDLDRIKVQQQFLGSLARQLKSEDTLTSPKKLYKVAEAATDALTVDSGIGSITKLMSLAKELQHINPKNITFVTLPVVDNPAEKVKATVVLNETDADPQQSALGQSLDVGRQLVDSLTDQDPRDGKTVPWLATRWKADPEATRFTFTLRAGATFSDGTPVDARAVKANFDAVHELGAAASRGAVYLDGYRETRVSGARTLTVVFDKPNAQFLRGTSTVSLGLLSPGSLRRTPQERCTGRLVGSGPFVLDRYRPNTSVTLDRRKGYSWGSRLWQREGGAYLEGVEYRIVPENTTRSGALSAGQLDVATALAPQDRERFSAPGWSLLTRTAPGVDLSLYVNARRTALREAAVRQALQKGIDREAVATTFLSSRKLAATSVLSSTTPGYTDLGDRLAHDPAGARRLLDKAGWRPGADGIRVKNGVRLRLDAVFVRQQSLELVQQQLKDIGVELRLRQLTVSRFPEVLAAGSYDLSLQSANRADPDVLTTAFAGGTPVADARLRSELRRATSSTDEATRSSLFAAAQRRLVDEGHVLPLNETEETAALSTRVHGLTRDASNRLVLHDTWTTG	MYKKVLIVATTTLFLSACSSKTVKQHQIHSISANQNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRSSTEYVPASTFKILNALIGLEHHKVTTTEVFKWDGQKRLFPDWEKDMTLGDAMQASAIPVYQKLARRIGLDLMSKEVKRVGFGNADIGSRVDNFWLVGPLKITPLQEAEFAYELAHKTLPFSKNVQEQVQSLVFIEEKNGRKIYAKSGWALDIDPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSIIRKEITYKGLEQLGIL	282.05	gnl|BL_ORD_ID|2496|hsp_num:0	3436			561	813	cloxacillin; oxacillin; cefalotin
BGC0000225.1|Frenolicin_8 # 5768 # 7342 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.783	BGC0000225.1|Frenolicin_8 	5768	7342	+	Loose	570	103.99	bcrA	29.74	3002987	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACCCCGGCGGACAAGCCGACCGACGAGCGCTCACCTGTCCTGGACCTCAGTGGTGTCAGCGTCGCCTACGGGACGCGCACCGTGCTGCACGGCATCGATCTGCGCCTCGCGCCGGGGCAGGTGCTCGCGGTGCTCGGCGCCTCGGGTTCCGGCAAGAGCACCCTCGCGCAGGCGGCTCTCGGCCTCCTGCCCCCCGGCGGCCGGGTGACGGCAGGGCGCGTCACGGTCGCCGGGCACGACATCACCGCGCTCGCGCCGCACCGGCTGCGCGCGCTGCGCGGCACGGTCACCGGACTCGTGCCGCAGGACCAGGCGGTCTCCCTCGACCCCCTCGTCCGCGTCGGCGCGCAGGTCACCGAGACGCTGCGCGCCCATCGCCTGGAGGACCGCCGCGAGGCCGCCCGGCGCGCCGTGCCCTTGCTCGGCGAGGCGGGGATCGAGGCCCCCGGGCCGCTCGCCCGCGCCTACCCGCACGCGCTCTCCGGCGGCCAACGCCAACGCGTCCTCGTCGCCGGGGCCTTCGCGGCCCGCCCCCCGCTGGTCGTCGCCGACGAGCCGACGAGCGCGCTCGACGCGACCGTGCGGCGCCGGGTCATGGACCGCTTCGCCGCCCTCGTCGCCGCGCACGGCACGGCCGTCCTCCTCGTCACCCACGACTTCCGGCTCGCGAGGGAACGCGCCGACCAGGTCGCCGTCCTCGCGGACGGCCGTCTCGTGGAGAGCGGCCCCGCCGCACGGGTCCTCGACCGGCCCGCCCACCCGTACACCCGCCGCCTCACGGGGGCCGGCCGCCGCGTGGCCGCACGGGGCACGGCGCCGCGCGCGTCGGGCACCCCCGTGGTGCGCGCCCGCGACCTCGTCAAGGAGTACCGGCGGGACGGGCGGCGGGTGCGCGCCGTGGACGGGGTCGGCTTCACGGTCCGCGAAGGCGAGTTCTTCGCCCTCGTCGGCGAGTCGGGCTCGGGCAAGTCCACGACCGCCCGGCTCGTGACGGGTCTGACCGCGCCCACGTCGGGCGCGGTGGAGCACGCGCCCGCTCCGGTGCGGCCCCAGCTCGTCCAGCAGAGCCCGTACGCGGCCTTCGACCCGCGCTGGACCGTGCGCCGCATCGTGGAGGAGCCGCTGCGGGCGCGGCACGTGCCCGGGGCGCGGCGGCGGGCGCGGCTGCGCGAACTGCTCGCGCTCGTCGGCCTCGACGAGGAGCTGCTCGCGCGGCGGCCCCGGGAGCTGTCCGGCGGGCAGCGGCAGCGGGTGGCGCTCGCCCGCGCGCTCGCCCCGGAACCGCGCCTGCTCGTGTGCGGCGAACCCGTCGCCGCCCTCGACCCCGTCGCGCGCGAGCGCGTCGTCCACCTCCTGGAGCGGCTGCGGGCGGAGCTGGGCCTCACGTGCCTCTTCGTCTCCCACGAGCTGGACGTCGTGCGGCGGTTGTGCGGTCGCGTCGCCGTCATGCGGGGCGGGCGGCTACTGGAGAGCGGACCGGTGGGGGAGGTGCTGTCGGCGCCCTCGCAGCCGTACACGCGGGCGCTGCTCGCCGCGGAGGCGGGCCCTTCCGACACGCCCGGAGCGGGGTGA	MTPADKPTDERSPVLDLSGVSVAYGTRTVLHGIDLRLAPGQVLAVLGASGSGKSTLAQAALGLLPPGGRVTAGRVTVAGHDITALAPHRLRALRGTVTGLVPQDQAVSLDPLVRVGAQVTETLRAHRLEDRREAARRAVPLLGEAGIEAPGPLARAYPHALSGGQRQRVLVAGAFAARPPLVVADEPTSALDATVRRRVMDRFAALVAAHGTAVLLVTHDFRLARERADQVAVLADGRLVESGPAARVLDRPAHPYTRRLTGAGRRVAARGTAPRASGTPVVRARDLVKEYRRDGRRVRAVDGVGFTVREGEFFALVGESGSGKSTTARLVTGLTAPTSGAVEHAPAPVRPQLVQQSPYAAFDPRWTVRRIVEEPLRARHVPGARRRARLRELLALVGLDEELLARRPRELSGGQRQRVALARALAPEPRLLVCGEPVAALDPVARERVVHLLERLRAELGLTCLFVSHELDVVRRLCGRVAVMRGGRLLESGPVGEVLSAPSQPYTRALLAAEAGPSDTPGAG	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	171.24	gnl|BL_ORD_ID|315|hsp_num:0	345			3	651	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000225.1|Frenolicin_9 # 7460 # 8110 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.747	BGC0000225.1|Frenolicin_9 	7460	8110	+	Loose	500	28.1054	CTX-M-234	37.5	3005657	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	GTGAACGAGATCACTGTCGAGATCTGGACCGACGTCGTCTGCCCGTGGTGCTACATCGGCAAGCGGCGCTTCGAGCGGGCGCTGGCCGCCTTCGACGCGAAGGAGGACGTGCGCGTCCACTGGCGCAGCTTCGAACTCGACCCCGCCGCCCTGCGGGTCACCGACGAGACCATCCCCGAGCGCATGCTGCGCCGCCAGGGCATCCCGCCCGAGCAGGCCGCCGAACTCCTCGCCGGGGTGAGCGCCCAGGCCGAGGCCGAAGGGCTGGAGTACCACCTCGACCGCGCCCGGCCCTGCAACACCTTCGACGCGCACCGGCTCGCCCACCACGCGGGCACGCGGGGCCTCGCGGAGACCTTCCAGGAACGGCTGATGTGCGCCTACACCGCCGAGGGCGTCTCGGTGGGCGACCACCCCACCCTGCTGGCCCTCGCCGAGGAGGCGGGGCTCGACGCGGCCGCCGCCGCCGAGGTGCTGGCCGGTGACGCGCACGCCGAGGACGTACGGGCCGACGAGGACCGGGCCGCCCGGCTCGGCGTCGGAGGGGTGCCCGCCTTCGTGATCGGCGGACGCTGGTCCGTCTCGGGCGCCCAGCCCGCCGAACTCCTCACCGGTCTCCTGGAACGGGCCCGGACCGCAGCCGCCGCCTGA	MNEITVEIWTDVVCPWCYIGKRRFERALAAFDAKEDVRVHWRSFELDPAALRVTDETIPERMLRRQGIPPEQAAELLAGVSAQAEAEGLEYHLDRARPCNTFDAHRLAHHAGTRGLAETFQERLMCAYTAEGVSVGDHPTLLALAEEAGLDAAAAAEVLAGDAHAEDVRADEDRAARLGVGGVPAFVIGGRWSVSGAQPAELLTGLLERARTAAAA	MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFPMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELSAAALQYTDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	74.23	gnl|BL_ORD_ID|3494|hsp_num:0	4563			369	513	
BGC0000225.1|Frenolicin_10 # 8271 # 9824 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.756	BGC0000225.1|Frenolicin_10 	8271	9824	+	Loose	1000	178.333	efpA	34.81	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCTCCTCCCCGCCCGCCCCCGCCACCCCGGGCGTTGCCCCGCACTCGCCGCCCGCTCCGCGCCTCGGCCTCGTGCTCCTCGTGTGCTGCCTGGCGCAGTTCCTCGTGACGCTCAGCGTCGCCATCGTCAACGTGGCGCTCCCCGACATCCAGCGCGGGCTCGGCTTCAGCGCCGAGAGCCTCCAGTGGGTCGTCAACGCCTACACCGTCACCTTCGCGGGCTTCCTGCTCCTCGGCGGACGGATCGCCGACCTCTTCGGGCGGCGCCGCATCTTCCTCGCGGGTGTCGCGCTCTTCGCCCTCGCGAGCCTCGCCGGGGGCCTAAGCCAGAACGCGGGGACCCTCGTCGCCGCGCGCGCCGTGCAGGGCCTCGCCGCCGCCGTCATCGCGCCCACCACCCTCGCCGTGCTCGGCACGAGCTTCAAGGACCCGCACCAGCGCCACCGCGCCTTCGGCGCCTGGGGCGCGGTCTCCGGTGCGGGCGGCGCCTTCGGCGCCCTCGCGGGCGGCGCGCTCACGGACGCGTTCTCCTGGCGCTGGGTGCTCTTCGTCAACCTCCCGATCGGCGTGCTCCTGCTCGCCGGGATCGCCTGGGGCATCAGCGAGTTGCGGCACGCGGGCGAGGACCGCCGCATCGACGTCGCGGGCGCCCTCACCGTGACGCTCGGTCTCCTCGCGCTCGTCCTCGGCATCGTGCAGAGCGGCCCGCACGGCTGGGGCTCCGCCGCCACCCTCGTCCCGCTCCTCGGCGGCCTCGCCCTGCTCGGTGCCTTCGTTCTCGTCGAGGGGCGGTTCGCGCCGCAGCCGCTCATACCGCTCGGCATCTTCCGCTCCCGCTCCGTCGTCGCGGCCAACGTCGTGGCGATGACCAGCGGCGCCGCGCTCTTCAGCATGTTCTACTTCCTCACCCTCTTCCTCAACCAGGTACGGGACTACAGCCCGCTGCGCACCGGCTTCGCCTATCTGCCGCTCGCGCTCGCCATCATGGTCGCCGCGCAGTTCTCCGCCGCGCTCGTGCGCGTCCTCGGCCCCCGTACGACCCTGCTCGTGTCCATGGCTCTCACCGCCGCCGGACTGCTCTGGCTCTCGCGGCTCACCGAGGACTCCGGGTTCGCGGGCGGACTCCTCGGCCCGACCCTGGTCGTCGGCATCGGACAGGGCATCTCGATGTCCGCCTCCGCGATCGCGGGGGTCGCCGGGGTGCGCCCGCAGCAGGCCGGGCTCGCCTCCGGGCTGCTCAACGCGACCCGGCAGCTCGGCGGCGCCCTCGGCCTCGCGGTCGTCGCCGCCGTCGCCACCTCGCGCGCCGACGGACTCCTCGACGGGGTCGCGCGGCCCACGGCGGAACTCGCCCGGCACGCCCAGGCGTCCGGGCACCCGCTCTCCATCGCCGTGGCCGCGGCGCTGTCCGCCGTCGGCCTGCTCGCCTCGCTCGCCGCCCCGGGCCGCTCTCCGGCCCCCACCGGCACCCGCACGGGCGGCGACTCCGCCGCACCGGCTCCCGCGGCGGCCCCCGCCGCCACCGGGACCACCGGCCCCGGCGAGATCTGA	MSSSPPAPATPGVAPHSPPAPRLGLVLLVCCLAQFLVTLSVAIVNVALPDIQRGLGFSAESLQWVVNAYTVTFAGFLLLGGRIADLFGRRRIFLAGVALFALASLAGGLSQNAGTLVAARAVQGLAAAVIAPTTLAVLGTSFKDPHQRHRAFGAWGAVSGAGGAFGALAGGALTDAFSWRWVLFVNLPIGVLLLAGIAWGISELRHAGEDRRIDVAGALTVTLGLLALVLGIVQSGPHGWGSAATLVPLLGGLALLGAFVLVEGRFAPQPLIPLGIFRSRSVVAANVVAMTSGAALFSMFYFLTLFLNQVRDYSPLRTGFAYLPLALAIMVAAQFSAALVRVLGPRTTLLVSMALTAAGLLWLSRLTEDSGFAGGLLGPTLVVGIGQGISMSASAIAGVAGVRPQQAGLASGLLNATRQLGGALGLAVVAAVATSRADGLLDGVARPTAELARHAQASGHPLSIAVAAALSAVGLLASLAAPGRSPAPTGTRTGGDSAAPAPAAAPAATGTTGPGEI	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	97.55	gnl|BL_ORD_ID|2188|hsp_num:0	2427			183	1383	rifampin; isoniazid
BGC0000225.1|Frenolicin_11 # 9893 # 10939 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.677	BGC0000225.1|Frenolicin_11 	9893	10939	+	Loose	400	28.8758	vanR gene in vanB cluster	30.36	3002921	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCGCGGGCCTTTTGCATGTGTGGGAAAGATGCGGGGCGTGCACATAATCACCGGCTTGCGCGCCGCGACTGTGTGCTGCGTCACGTTTCACGTGGTGTCTATATTTCCCTGTCTATTCTTGGCACCGCTCGGAGGGGGACCGGTGCGCGCTGCCGTTTATCCCGCCGGACGTCATGATGTCCACCGGGAGGGAAACGTGGAAATCAAGTACATGGGTCAGTTGACCATGCGGTGGGAGGGGCGGGAAAAGCTCCCCTCGGCGCGCAAGCCGCGCACCGTGCTCGCCCTTCTGCTCCTCAACGACAAGACACCCGTCACGACCAGCGCACTCATCACGGAACTCTGGGGCGAGAACCCGCCGCGCAGCGCCCTGACCACCCTCCAGACCTATATTCTCCAGCTCCGGAAATGCCTCGCGGCGATGAGCGGGCGAAGCCTCGCCTGCATATCCGAGAAAACCCTGGTGACGTGGCCCTGCGGTTATCTGGCGCGGCTTCCGGCGGACGCCACTTCGGATGTGGCTGAATTCCGTCGGTTTGCCAGGGAGGGGCGGGAAGCGGAACGCAGGGGTCATCTTGCCGAGGCCGTCCGCTCCTACCGCGCGGCGCTGTCACTGAGCCAGGGACCACTCCTCGCCGATATCGAGCACGGGCCGCTGCTGCGCGCCGAGGCGGTACGCATGGAGGAGTGCCGGCTTTCGCTCGTCGAACGCTCCATCGAGGGCGACCTGCTCCTCGGCCGGCACCGGGAGGTCGTCAGCGAACTGTCCGCCCTCGTCGCCCAGTACCCCTACCACGAACAGCTCACGGGGCAGCTCATGGTCGCGCTCGTGCGCTGTGGCCGCCGGCAGGACGCGCTCGCCGTGCACCAACGGCTCCGGGCCCGCATGGTGGAGGACCTCGGCCTCGAACCGAGCAGCCACCTGCGCGCCCTGCAGTCCGCCGTCCTCAGCGGCGAGCCGCTGCCGGGACCGCCCGGAACCGGTGGCGAGATCCCCACCCCCTACGCGGGCGCTTTCGCCACCGCGGCGCGCTCGCACGACTGA	MRGPFACVGKMRGVHIITGLRAATVCCVTFHVVSIFPCLFLAPLGGGPVRAAVYPAGRHDVHREGNVEIKYMGQLTMRWEGREKLPSARKPRTVLALLLLNDKTPVTTSALITELWGENPPRSALTTLQTYILQLRKCLAAMSGRSLACISEKTLVTWPCGYLARLPADATSDVAEFRRFAREGREAERRGHLAEAVRSYRAALSLSQGPLLADIEHGPLLRAEAVRMEECRLSLVERSIEGDLLLGRHREVVSELSALVAQYPYHEQLTGQLMVALVRCGRRQDALAVHQRLRARMVEDLGLEPSSHLRALQSAVLSGEPLPGPPGTGGEIPTPYAGAFATAARSHD	MSIRILLVEDDDHICNTVRAFLAEARYEVDACTDGNEAHTKFYENTYQLVILDIMLPGMNGHELLREFRAQNDTPILMMTALSDDENQIRAFDAEADDYVTKPFKMRILLKRVEALLRRSGALAKEFRVGRLTLLPEDFRVLCDGTELPLTRKEFEILLLLVQNKGRTLTHEIILSRIWGYDFDGDGSTVHTHIKNLRAKLPENIIKTIRGVGYRLEESL	158.18	gnl|BL_ORD_ID|153|hsp_num:0	141			438	603	vancomycin
BGC0000225.1|Frenolicin_12 # 11033 # 11548 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.750	BGC0000225.1|Frenolicin_12 	11033	11548	-	Loose	500	23.8682	OXA-896	35.71	3006087	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGAACGAGACACGGACGGCCGCGCGGACGGGGCAGGTCGGGCCGGTCGATGCCGAGGGCTTCCGCGCCGCGATGTCGTGCTTCCCCGCGGGGGTGGTCCTCGTGACGACGCGCGAGGAGGACGGCACCCCCCGCGGTTTCACGGCGAGTTCCTTCTGCTCGGTGTCGCTCGCTCCCCCGCTGGTGTCGGTGTGCCAGGGCACGGGCGCGCAGTCCTACGGGGCGTTCCAGGAGTGCGCGCGGTTCGCGGTGAGCGTGCTGCGGAGCGGACAGCGGGAGCTGGCCTCGCGGTTCGCGACGCGCGGGGCGGACAAGTTCGGGGGCGGGGGGCTCGTGGCGCTGGAGGGCTCGGGGCTGCTGGTCGCGGCGGACGCGCTCGTCACGCTGGAGTGCGCGGTACACGCCCGGCACCTGGCCGGGGACCACGTGATCCTCGTCGGCGAGGTGCGCGGGGTGGGGCAGGGTGAGGGCGAACCGCTCGTGCACTGGGAGCGGGGGTTTCGCGCGCTGCGCTGA	MNETRTAARTGQVGPVDAEGFRAAMSCFPAGVVLVTTREEDGTPRGFTASSFCSVSLAPPLVSVCQGTGAQSYGAFQECARFAVSVLRSGQRELASRFATRGADKFGGGGLVALEGSGLLVAADALVTLECAVHARHLAGDHVILVGEVRGVGQGEGEPLVHWERGFRALR	MKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVSPCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVVWFSQQLTSRLGVDRFTEYVKKFEYGNQDVSGDSGKHNGLTQSWLMSSLTISPKEQIQFLLRFVAHKLPVSEAAYDMAYATIPQYQAAEGWAVHGKSGSGWLRDNNGKINESRPQGWFVGWAEKNGRQVVFARLEIGKEKSDIPGGSKAREDIPVELPVLMGNK	62.41	gnl|BL_ORD_ID|4122|hsp_num:0	5192			63	147	cloxacillin; oxacillin; cefalotin
BGC0000225.1|Frenolicin_13 # 11545 # 12537 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.751	BGC0000225.1|Frenolicin_13 	11545	12537	-	Loose	920	26.1794	OpmD	38.0	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTCGGTACGCGGCCTGTCGTGCACAGCAGGCTCTTGGGGGTGGGGGGTTACCGGCCCCGGCGCAGTGTGGACAACGCCGAACTGTGTGCCACGGTCGCGTCGACCCCGGAGTGGATAGAGACCCGCAGCGGTATCCGTGCGCGCGGCTTCGCCGCGCCGGACGAGACCTTGCGGTTCATGGGGCGGGCGGCGGCCGAGAAGGCGCTCGCGCGGGCGGGGGTGCTGCCGGACGGGATCGATCTGGTGCTGGTGGCGAGCATGTCGCGGCTGGAGCAGACGCCCCCGCTCGCCGTGCTCCTCGCCGAGGACCTCGGCGCGCGGGCGGCGGCGGGGCTGGACGTGTCCGGCGCCTGCGCCGGTTTCTGCCACGCGCTGGCGCTCGCTTCGGACGCGGTGCGCGCCGGGAGCGCCCGGCACGTCCTGGTGGTGGGCACGGAGCGGATGACGGATCTCGTGGAGCGTGCGGACCGCACCGTCTCCGTGCTCTTCGCGGACGGGGCGGGAGCCGCTGTGGTGGGGCCTTCGGCGCGGCCGGGGATCTCGCCGCCGGCGCGTGGTGCGGCGGGCCGGTACGCCGGAGCGCTGCGGATGGACAGGGGCTGGGACACGTTCGCCGCCGATCCCTCGCTCGGCAGGCCGTGGATGCGGATGGACGGACGGCGGGTGTTCCGCTGGGCGATGGACGAGGTGACCCCGCGGGCGGCGGAACTGCTGCGGGAGAGCGGGATCGAGCCGGAGGCGCTGGACGCCTTCGTCCCGCACCAGGCGAACCTGCGCATGATCGAGCTGATGGCCGAACGGCTCGGCCTGCCGGAGCGCACGGCCGTGGCGCGGGACGTGGTGCGCGCCGGGAACACCTCGGCGGCCTCGGTCCCGCTCGCGCTGGAGGCGCTCCTCGACTCCGGCGAGGTGGGCAGCGGGGACCGCGCGCTCCTCGTGGGGTTCGGCGCGGGGCTCAACTACGCGGCCCAGGTGGTGGAGCTCCCGTGA	MLGTRPVVHSRLLGVGGYRPRRSVDNAELCATVASTPEWIETRSGIRARGFAAPDETLRFMGRAAAEKALARAGVLPDGIDLVLVASMSRLEQTPPLAVLLAEDLGARAAAGLDVSGACAGFCHALALASDAVRAGSARHVLVVGTERMTDLVERADRTVSVLFADGAGAAVVGPSARPGISPPARGAAGRYAGALRMDRGWDTFAADPSLGRPWMRMDGRRVFRWAMDEVTPRAAELLRESGIEPEALDAFVPHQANLRMIELMAERLGLPERTAVARDVVRAGNTSAASVPLALEALLDSGEVGSGDRALLVGFGAGLNYAAQVVELP	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	67.76	gnl|BL_ORD_ID|450|hsp_num:0	442			57	204	acriflavine; tetracycline; norfloxacin
BGC0000225.1|Frenolicin_14 # 12736 # 12993 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=11bp;gc_cont=0.659	BGC0000225.1|Frenolicin_14 	12736	12993	+	Loose	400	25.7942	vanR gene in vanF cluster	18.37	3002925	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGAGCGCCTTCACTCTCACCGAGTTCAAGAAGCTGGTCGAGCAGAGCTACGACGCCGAATCGGCCGAAGCCCTCCACGGGCAGGCCCTCGACACGAGCTTCACCGATCTGGGTTACGACTCGCTGACGGTCTACGAGATCGTCACCCGCATCCAGGACGAGCACGGAGTCACCGTGCCCGACGAGGAGCTGGACCTCCTCGACACCCCGCGCGCCCTCATCGCGTACGTCGACGCGCGCGCGGGTTCCCGCACCTGA	MSAFTLTEFKKLVEQSYDAESAEALHGQALDTSFTDLGYDSLTVYEIVTRIQDEHGVTVPDEELDLLDTPRALIAYVDARAGSRT	MKNITILIADDDAEIADLVAIHLEKEGYRVIKVSDGQETIDVIQNQPIDLLILDIMMPKMDGFEVTRRIREKHNMPIIFLSAKTSDFDKVQGLVIGADDYMTKPFIPIELVARVNAQLRRFMKLNQPKTKQNSNLEFGGLTISPEQRTVTLYGKNIELTPKEFEILFLLASNPNKVYRAEDIFQKVWGDAYYEGGNTVMVHIRTLRKKLEEDKRKNKLIQTVWGVGYKFNG	36.80	gnl|BL_ORD_ID|298|hsp_num:0	240			84	231	vancomycin
BGC0000225.1|Frenolicin_15 # 13081 # 14136 # -1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.795	BGC0000225.1|Frenolicin_15 	13081	14136	-	Loose	550	25.409	RAHN-2	46.88	3006980	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	RAHN beta-lactamase	GTGCGGAGCGAGGGCGGTACGGAGGAGGAGGGCGCCCCGGTGGTGGCCCTGCTGCTGCCCGGTCAGGGCGCGCAGCGGGCCCGGATGGCGGCCGGACTCCACGGCGTGGTGCCGGAGTTCACGACCGCGGTGGAGGAGTGCTTCGCCGTGTGGGGCACCTGGGGGGAGGAGTTGCGCGCGCGGTGGCTGGACGGGGCGGGCGGCGAGGAGGCGCTGGAACGGGCCGCTGTCGCGCAGCCGTTGCTCTTCGCCGTGGGGTACGGGCTCGGGCGGGCGCTCGGCGCGGGGGCGCAGGGTGCGCCGCACCTGTTGCTCGGGCACAGCGTCGGCGAACTCGCCGCCGCCGCGCTCGCCGGGGTGTGCGCGCCGGGGGCGGCGCTCCGGCTGCTCGCCGAACGGGACGCGGTGCTGCGCGCGGCGCCGTCCGGGGGCATGCTCGCCGTGGCCGCGCCGGTGGACGACCTGCGCCCGTACGTGGGGGCCGACGTGGTGGTGGGCGCGGTGAACGGGCCGCGTCAGACGGTGCTGTGCGGGCCGGAGGCGCCGCTGCGCGCGGTGGCGCGGCGCCTGGCCGACGACGGGCTGACGGCGCGCCGCCTCCAGGCGGACGTACCCTTCCACTCCCCCGCCCTCGCCGGGGCGGCGCGGCGTCTGACCAGGGCGAGCGCGGAACGGGTCGCGCGGTGGCGGCCACCCGCCGTGCCCCTGTGGTCGGGCCGGACGGGTCGCGCGCTCACGCCGGGCGAGGCGGTGCGCGCCGCGTTCTGGTGCGGTCAGCTCGCCGCCCCCGTCCTGTACTGGCCGGCGCTGGGGAACCTGCTCGCGACGGCGACGGCGACGGCGACGACCACGGGCGGCGGGCGTGGCGTGGTGCTGCTCGACGCCTCGCCGGACGGCAGTCTCGGCGCCCCGGCGCGCCGTCATCCGGCCGTCCGCTCGGGCGCGGCCCGTGTCGTTCGGCTCCTGCCCGCGCGTCCCGGCGACCCCGCGGACGACGTGCGGGCCTTTCGCGCCGCGCTCCAACAGGCGGGTCAGGTCGTACGGGACGGGGGCTGA	MRSEGGTEEEGAPVVALLLPGQGAQRARMAAGLHGVVPEFTTAVEECFAVWGTWGEELRARWLDGAGGEEALERAAVAQPLLFAVGYGLGRALGAGAQGAPHLLLGHSVGELAAAALAGVCAPGAALRLLAERDAVLRAAPSGGMLAVAAPVDDLRPYVGADVVVGAVNGPRQTVLCGPEAPLRAVARRLADDGLTARRLQADVPFHSPALAGAARRLTRASAERVARWRPPAVPLWSGRTGRALTPGEAVRAAFWCGQLAAPVLYWPALGNLLATATATATTTGGGRGVVLLDASPDGSLGAPARRHPAVRSGAARVVRLLPARPGDPADDVRAFRAALQQAGQVVRDGG	MMKNTLRKTVLMAAAVVPMLAFSAVSWAQTATKMTSVQQQLTALEKESGGRLGVMLINTEDNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLTRSDLVNYNPITEKHLDTGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAIPGDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDKTGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKSRRDVLASAAKIVTPGY	118.98	gnl|BL_ORD_ID|4567|hsp_num:0	5637			354	444	
BGC0000225.1|Frenolicin_16 # 14336 # 15613 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.731	BGC0000225.1|Frenolicin_16 	14336	15613	+	Loose	750	192.2	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	31.14	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAACCGACAAGTCGCCGTCACCGGCATCGGCGTGGTGGCTCCGGGAGGGATCGGGCGCAAGCCGTACTGGGAGCAGCTCACCTCCGGACGCACCGCCACGCGCGCCATCTCCTTCTTCGACGCCTCGCCCTTCCGCTCGCGGATCGCCGCCGAGGTCGACTTCGACCCCGCGGCGGCGGGCCTGAGCCCGCGCGAGGTCCGCCGCATGGACCGGGCCGCGCAGTTCGCCGTCGTGAGCGCCAGGGAGAGCCTCGCCGACAGCGGACTCGACGTCGCCGACCTCGACCCCCACCGGATCGGGGTGAGCATCGGCAGCGCCGTGGGCGGGACCACCTCGCTGGAACGCGAGTACCTCGCCCTCAGCGACAGCGGGCGACAGTGGGAACTCGACCTCTCCTACCTCTCGCCGCACCTCTACGACGCCTTCACCCCCAGCTCGCTCGCCCGCGAGGTGGCCGGGGTGATCGGCGCGGAGGGGCCCGCGGCAGTCGTCTCCACCGGCTGCACCTCCGGCATCGACTCGCTCGGCCACGCCCGCGACCTCATCGCCGAGGGCAGCGCCGACGTCGTGCTCGCGGGCGGCACCGACACCCCCATCTCGCCGATCGCCGTCGCCTGCTTCGACGCCATCAAGGCCACCTCGCCCAGCAACGACGACCCGGCGCACGCCTCGCGCCCCTTCGACAGGGAACGCAACGGCTTCGTCCTCGCGGAGGGCGCCGCCGTCCTCGTGCTGGAGGAGCTGGGGCACGCGCGGGCCCGCGACGCCCACGTCTACGCTCTCGTGTCCGGCTACGCCACGCGCTGCAACGCGTACCACATGACCGGGCTCACCCCGCACGGCAGGGAGATGGCCGAGGCGATCCGGCACGCGCTCGCCGAGAGCGGGACCGACCCCGCCGCCGTGGACTACGTCAACGCCCACGGCTCCGGCACCAAGCAGAACGACCGGCACGAGACCGCCGCCTTCAAGGCCACGCTCGGCGAGCGGGCCAGGAGCGTGCCGGTCAGCTCCATCAAGTCGATGATCGGCCACTCGCTCGGTGCCATCGGTTCGCTGGAGATCGCGGCCTGGGCGCTCGCCATGGAGTACGGCGTGGTGCCGCCCACCGCCAACCTCGACACGCCCGACCCCGAGTGCGACCTCGACTACGTGCCCCACGAGGCGCGCGAGACGCGGGTGGACAGGGTCCTGAGCGTCGGCAGCGGCTTCGGCGGTTTCCAGAGCGCCATGGTCCTCACCCGGGACACGGGCGCCCGCCTCCCGACGGCCTGA	MNRQVAVTGIGVVAPGGIGRKPYWEQLTSGRTATRAISFFDASPFRSRIAAEVDFDPAAAGLSPREVRRMDRAAQFAVVSARESLADSGLDVADLDPHRIGVSIGSAVGGTTSLEREYLALSDSGRQWELDLSYLSPHLYDAFTPSSLAREVAGVIGAEGPAAVVSTGCTSGIDSLGHARDLIAEGSADVVLAGGTDTPISPIAVACFDAIKATSPSNDDPAHASRPFDRERNGFVLAEGAAVLVLEELGHARARDAHVYALVSGYATRCNAYHMTGLTPHGREMAEAIRHALAESGTDPAAVDYVNAHGSGTKQNDRHETAAFKATLGERARSVPVSSIKSMIGHSLGAIGSLEIAAWALAMEYGVVPPTANLDTPDPECDLDYVPHEARETRVDRVLSVGSGFGGFQSAMVLTRDTGARLPTA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.16	gnl|BL_ORD_ID|1968|hsp_num:0	1943			96	1245	isoniazid
BGC0000225.1|Frenolicin_17 # 15694 # 16974 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.786	BGC0000225.1|Frenolicin_17 	15694	16974	+	Loose	750	112.464	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.87	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCACCGCCCCCTCCCGCACCGCCCAGGGCGCCCCTCCCGGGGCCGCCCTGCCCCCCGTCTTCACCGGCATCGGCGTCGCCGCCCCCAACGGGCTCGGCACCGAGGAGTGGTGGGCGGCCACCCTGCGCGGGGAGCACGGTCTGCGGCCCGTCACGGAGTACGACGCGAGCGGCCACCCCGGTGGACTCGTCGGCCGCGTCCCGGACTTCGACGCCGCCCGCCACCTGCCCGGCCGCCTCCTGCCGCAGACCGACCGGGTCACCCGGCTCGCGCTCGTCGCCGCCGACGAGGCACTGAAGGACGCCGCCGTCGACCCGGCCCGGCTGCCCGAGTACGGGGCGAGCGCCGTCACCTCCAACGCCACCGGCGGCTTCGAGTTCACCCACCGCGAGATCCGCAAACTCTGGACCGAGGGCCCGGCCCGCGTCAGCGTCTACGAGTCCTTCGCCTGGTTCTACGCCGTCAACACCGGCCAGATCTCCATCCGGCACGGCATGCGCGGCCCCGGCGCCGTCGTCGTGGCCGACCAGGCGGGCGGCCTCGACGCCCTCGGCCAGGCCCGCCGCGTACTGCGCAAGGGCGGGGTGCTGGCGGTGAGCGGCGGCGTGGAGTCCGCGCTCGACCCCTGGGGCCTGGCCGCCCACGCCTCGTCGGGCACCCTCAGCCGCTCCGGCGACCCGGCCACCGCCTACCTCCCCTTCGACCGGCGTGCCCTCGGCACCGTCGTCGGCGAGGGCGGCGCCCTCCTCACCCTGGAGACACCCCGGCACGCCGAGGAGCGCGACGCACCCCGGATCTACGGCGAACTCGCCGGGTACGCCGCCACGTTCGACCCGCCCGCGGGCTCCGGACGGCCCCCCGGCCTCGAACGCGCCGCGCGCCTCGCCCTCGCCGACGCGGGCCTGGCACCCGGGGACGTCGACGTCGTCTTCGCGGACGCGGCGGGGCTCCCCGCCGCCGACGCCGCCGAGGCCGCCGCCCTGCGCGCGCTCTTCGGCCCCGGCGGCGTTCCGGTGAGCGTGCCGAAGACCCAGACCGGGCGGCTCGCCTCGGGCGGCCCGGCCCTCGACGTCGCCGCCGCCCTCCTCGCCCTGCGCGACGGCCTCGTGCCCCCGGCCGTCCACCTCGACGAGGTCGATCCCGCGTACGGCCTCGACCTCGTCCGCGACACCCCGCGCGCCCTCCCGCTGCGCACGGCGCTCGTCCTCGCGCGCGGCCACGGCGGCTTCAACGCGGCCGTCGTCGTCCGCGGGCGGCGGCGGCCCCGTACCGCCTGA	MTTAPSRTAQGAPPGAALPPVFTGIGVAAPNGLGTEEWWAATLRGEHGLRPVTEYDASGHPGGLVGRVPDFDAARHLPGRLLPQTDRVTRLALVAADEALKDAAVDPARLPEYGASAVTSNATGGFEFTHREIRKLWTEGPARVSVYESFAWFYAVNTGQISIRHGMRGPGAVVVADQAGGLDALGQARRVLRKGGVLAVSGGVESALDPWGLAAHASSGTLSRSGDPATAYLPFDRRALGTVVGEGGALLTLETPRHAEERDAPRIYGELAGYAATFDPPAGSGRPPGLERAARLALADAGLAPGDVDVVFADAAGLPAADAAEAAALRALFGPGGVPVSVPKTQTGRLASGGPALDVAAALLALRDGLVPPAVHLDEVDPAYGLDLVRDTPRALPLRTALVLARGHGGFNAAVVVRGRRRPRTA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.40	gnl|BL_ORD_ID|1968|hsp_num:0	1943			87	1233	isoniazid
BGC0000225.1|Frenolicin_18 # 17047 # 17298 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.694	BGC0000225.1|Frenolicin_18 	17047	17298	+	Loose	550	22.7126	Nocardia farcinica rox	50.0	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAGCGCACTGACCGTCGACGACCTCAAGAAACTGCTCGCCGAGACCGCCGGGGAGGACGACAGCGTCGACCTCGCCGGAGAACTCGACACGCCCTTCGTGGACCTCGGCTACGACTCCCTCGCGCTGCTGGAGACGGCCGCCGTGCTCCAGCAGCGGTACGGCATCGCGCTGACTGACGAGACGGTCGGCCGGCTGGGCACCCCGCGCGAACTGCTCGACGAGGTCAACACCACCCCGGCCACCGCCTGA	MSALTVDDLKKLLAETAGEDDSVDLAGELDTPFVDLGYDSLALLETAAVLQQRYGIALTDETVGRLGTPRELLDEVNTTPATA	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	17.55	gnl|BL_ORD_ID|4834|hsp_num:0	5821			675	741	rifampin
BGC0000225.1|Frenolicin_19 # 17273 # 17383 # -1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=12bp;gc_cont=0.784	BGC0000225.1|Frenolicin_19 	17273	17383	-	Loose	1900	21.1718	MexW	58.33	3003031	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGGTCCGCCGCGAACGAAGGGTCCGGCCCCACCCCCCGCGCGGGGGGTGGGGCCGGACCCTTCGTTCGCGTGCGCCGCCCGCTCAGGCGGTGGCCGGGGTGGTGTTGA	MRSAANEGSGPTPRAGGGAGPFVRVRRPLRRWPGWC	MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH	3.54	gnl|BL_ORD_ID|2018|hsp_num:0	2208			2241	2277	erythromycin; acriflavine; tetracycline; chloramphenicol
BGC0000225.1|Frenolicin_20 # 17380 # 17862 # -1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.741	BGC0000225.1|Frenolicin_20 	17380	17862	-	Loose	500	25.409	PER-6	47.83	3002368	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam; penem	antibiotic inactivation	PER beta-lactamase	GTGACGACCACCACCCCGCCGGACGACGTGAGGGCCGGGTCCCTGCCGGGCGACGCGGCGCGTTCCGCGGCGCTCTACACCGAGGTACAGGCGTTCTACGCGCGCCAGGCACACCACCTGGACGCGGTACGGGCCGAGGAGTTCGCGGCCACCTTCGCGGCGGAGGGCGTCTTCGCCCACTCCCCCGACACCCCGGCGGCCCGGGGCAGGGCGGCGATCGCGGAGGAGGTGCGCGGCTTCAACGCCCGCCGGTTCGCCGACGACCCCGTCCAGCGGCGGCACTGGTTCTCGATGCTGGACGTACGCCCGGGTGAGGACGGCGCCGTCGAGACGGAGTTCTACGCGCTGGTCGTGGTGACCCGGCCGGACGCGGCGCTCCCGGTGATCGGTCCCAGTTGCGTCGTACGGGACGTCCTGGTGCGGGAGGGCGGGGAACTGCGCACGCTGTCGCGGCAGGTGACCCAGGACCGCACCTTGCTGTGA	MTTTTPPDDVRAGSLPGDAARSAALYTEVQAFYARQAHHLDAVRAEEFAATFAAEGVFAHSPDTPAARGRAAIAEEVRGFNARRFADDPVQRRHWFSMLDVRPGEDGAVETEFYALVVVTRPDAALPVIGPSCVVRDVLVREGGELRTLSRQVTQDRTLL	MNVIAKGVFTTTALLMLSLSSWVVSAQSPLLKEQIETIVTGKKATVGVAVWGPDDLEPLLVNPFEKFPMQSVFKMHLAMLVLHQVDQGKLDLNKTVAVNRAAVLQNTWSPMMKDHQGDEFTVTVQQLLQYSVSHSDNVACDLLFELVGGPAALHAYIQSLGIKETEVVANEAQMHADDQVQYKNWTSMKAAAQLLRKFEQKKQLSETSQALLWKWMVETTTGPQRLKGLLPAGTVVAHKTGTSGVRAGKTAATNDIGVIMLPDGRPLLVAVFVKDSAESARTNEAIIAQVAQAAYQFELKKLSAVSPD	51.95	gnl|BL_ORD_ID|1375|hsp_num:0	1493			495	564	
BGC0000225.1|Frenolicin_21 # 18015 # 18830 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=11bp;gc_cont=0.735	BGC0000225.1|Frenolicin_21 	18015	18830	+	Loose	400	25.7942	ErmW	32.0	3001306	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACCACAGCAGCTCCGCACACCCGCCCCGGGGAGGCAGGCACCACCCGGGGACCCGCTCTCGTGACCGGCGCGACCCGGGGCATCGGCCTCGCCGTCGCCGAGGCGCTCGTCGCGCGCGGCTATCCCGTGGTGGTCTGCGCCCGCGACGCCGAGGCGGTCGCGCGCACCGTCAAGGAGCTGGCAGCGGGCGGCGCCCGCGTCGAGGGCGTCGTCGCCGACGTCACCGACGCCGCCTCCGTGCACGAACTCGTCGCCACCACCGTCGCCCGCTTCGGCCCCGTCGAGGTCCTCGTCAACAACGCGGGCCGGTCCGGCGGCGGAGTGACCGCCGAACTCAGCGAGTCCCTGTGGGACGACGTCATCGCCACCAACCTCAAGAGCGTCTTCCTGGTCACCCGGGAGGTGCTCACCACGGGCGGGATGACCGGGCGCGGCCGCGGCGTCGTCAACATCGCCTCCACGGGCGGCAAGCAGGGCGTCGTCTTCGGCGCCCCCTACTCGGCGTCCAAGCACGGCGTCGTCGGCTTCACCAAAGCCCTCGGCCTCGAACTGGCCCGGAGCGGCATCACCGTCAACGCCGTCTGCCCCGGCTACGTCGAGACGCCGATGGCCGCCGGAGTGCGCCGCCACTACGCCGACCTGTGGGACGTCACCGAGGAGGACGTGCTGGCCCGCTTCGAGGCGAAGATCCCGCTCGGCCGGTACACCCGCCCCGACGAGGTCGCCGCCCTCGTCGACTACCTGGTCACCGACGCCGCCGCGGCCGTCACCGCCCAGGCCCTCAACGTGTGCGGCGGACTGGGGAACTACTGA	MTTAAPHTRPGEAGTTRGPALVTGATRGIGLAVAEALVARGYPVVVCARDAEAVARTVKELAAGGARVEGVVADVTDAASVHELVATTVARFGPVEVLVNNAGRSGGGVTAELSESLWDDVIATNLKSVFLVTREVLTTGGMTGRGRGVVNIASTGGKQGVVFGAPYSASKHGVVGFTKALGLELARSGITVNAVCPGYVETPMAAGVRRHYADLWDVTEEDVLARFEAKIPLGRYTRPDEVAALVDYLVTDAAAAVTAQALNVCGGLGNY	MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAITRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSITTPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDPVPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLRRERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSGPPRARRRGGGA	87.14	gnl|BL_ORD_ID|1572|hsp_num:0	1714			126	342	erythromycin; josamycin
BGC0000225.1|Frenolicin_22 # 18830 # 19825 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.766	BGC0000225.1|Frenolicin_22 	18830	19825	+	Loose	1500	26.1794	rphA	41.67	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGACCACCACCACGACCGGGCACCAGCGCCCCGGCTCCGCCGAACACTCCGCGCGCCTCGCCGCCCCGCCCGCCTCCGCCTACGAACTCGTCGCCGACGTGACGCGCTGGCCCCTCCTCTTCACCCCGTGCCTGCACGCCGAGGTGCTGGAGAGCGGTCCCGGCACCGAACGCGTGCGGCTGTGGGCCCTCACCGGCGAGCAGGTGCGCGGCTGGACCTCGCGGCGCACCCTCGACAGCGAGGGCCTGCGCGTCGGCTTCCGCCAGGAGGACAGCGCCCCGCCGCTCGCCGCGATGGGCGGGGAGTGGCGCTTCACCGAGGAGGGCGAGGACACGCGCGCCGTACTCGCGCACGACTGGACGCTCACCGAGCCGGGCGCCGCACCGCACCGCTGGGTCACCGAGACACTCGACCGCAACAGCACCGCCGAGATCGGGGCCGTGACCGCCTGGGCCGCGCGCACCCACGCGGCGGGCGGCGCCGACGCGCTGCTCTTCTCCTTCACCGACAGCCTCGACATCGCCGCCCCCGCGCCCGACGTGTACGCCTTCCTCGACGCCGCCGACCAGTGGCCCGCGCGGCTCCCGCACGTCAGCCGGGTCGCCTTCTCGACCACCCCGGCGACGCCGCTCACGGCGGGCGCGGAGGTGCAGCACCTGGAGATGGAGACGCGCGCGGACGACGGCACGCGCCACCTCACCCGCTCGATCCGCCTCGGCTTCGCGGGCCGTCTCCTCGTCTACAAGCAGACCACGTTGCCCGCCCCGCTCCTCGGCCACGCCGGCTCCTGGGCGCTGGAGCCGCTGCCCGGCGGCGGCACCCGGGTCACCGCCCGCCACCGGGTGGCACTCGACCCGGACGCCGTGACCGAACGCTTCGGCGCGGGGACCACGCTCGCGGCGGCGCGGGACACGGTACGGGCGCTGCTCGGCGGCAACAGCAGGCGCACCCTGGAGGCGGCCCGCGCCCACACCGAGTCGGCGGGGGAGCGATGA	MTTTTTGHQRPGSAEHSARLAAPPASAYELVADVTRWPLLFTPCLHAEVLESGPGTERVRLWALTGEQVRGWTSRRTLDSEGLRVGFRQEDSAPPLAAMGGEWRFTEEGEDTRAVLAHDWTLTEPGAAPHRWVTETLDRNSTAEIGAVTAWAARTHAAGGADALLFSFTDSLDIAAPAPDVYAFLDAADQWPARLPHVSRVAFSTTPATPLTAGAEVQHLEMETRADDGTRHLTRSIRLGFAGRLLVYKQTTLPAPLLGHAGSWALEPLPGGGTRVTARHRVALDPDAVTERFGAGTTLAAARDTVRALLGGNSRRTLEAARAHTESAGER	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	38.27	gnl|BL_ORD_ID|890|hsp_num:0	910			669	777	rifampin; rifaximin; rifabutin; rifapentine
BGC0000225.1|Frenolicin_23 # 19822 # 20766 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.750	BGC0000225.1|Frenolicin_23 	19822	20766	+	Loose	450	71.633	cphA2	28.23	3003099	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	ATGACCACGACCGGCCCCGCGACTCCCCTGGCCCCCGGGCCCGCATCCGCCGAGACCGTCGCGCTCGCCGACGGCGTGCACTCCTGGCTCCAGCCCGACGGCGGCTGGTGCGTCAGCAACGCGGGCATCCTGCTCGCGCCCGACCGCGTCGCGCTCGTCGACACCGCCGCCACCGAGGCGCGCTCCCGCGCGCTCGGCGCCGCGGTCGCCGGACTCAGCCCGCATCCCGTGCGACTGCTCGTCAACACCCACTTCCACGGGGACCACAGCTTCGGCAACGGCATCCTCGGCAAGGACGCCGTCATCGTCGCCCACGAGCGCACCCGCACCGAGATGGCCGAGGCCGGACTCGGGCTCACCGGACTGTGGCCGGGCGTGGACTGGGGGCACGTGGACCCGGTCCTGCCCCAGCTCACGTACCGCAGGCGCCTCACGCTCCACCACGGGGACCTCCGCGTCGAGCTGATCCACCCCGGCCCGGCGCACACCACCAACGACACCCTGGTGTGGCTCCCCGAGCAGCGCGTCCTGTTCGCGGGGGACGTACTCCTGCCGGGGGCGACGCCCTTCGTGCTGATGGGCTCGGTGACCGGCTCGCTGCACACCCTGCGTCTGCTGCGCCGCCTCGGCCCCCGCGTCGTCGTCGGCGGGCACGGCCCCCTCGCGGGGCCCGAGGTGATCGAGGAGACGGAGCGCTACCTGCTGCGGCTGCGGCGCATCGCCACCGAGGGCCACGCCGCGGGGCTCACCCCGCTGGAGGCGGCACGGCGCCACGGCCCCGGGCCCTTCGCCCACTGGAGCGAGCCGGAACGACTCGCCGCCAATCTGCACCGGGCGTACGCCGAACTCGGCCCCGCACCACTGGGCACGCCGCTCGACGTCCTCGCCTGCTTCGGCGACCTCATCGCCTACAACGACGGCGAGCTGCCGGTCAGCCACGCCTGA	MTTTGPATPLAPGPASAETVALADGVHSWLQPDGGWCVSNAGILLAPDRVALVDTAATEARSRALGAAVAGLSPHPVRLLVNTHFHGDHSFGNGILGKDAVIVAHERTRTEMAEAGLGLTGLWPGVDWGHVDPVLPQLTYRRRLTLHHGDLRVELIHPGPAHTTNDTLVWLPEQRVLFAGDVLLPGATPFVLMGSVTGSLHTLRLLRRLGPRVVVGGHGPLAGPEVIEETERYLLRLRRIATEGHAAGLTPLEAARRHGPGPFAHWSEPERLAANLHRAYAELGPAPLGTPLDVLACFGDLIAYNDGELPVSHA	MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPRTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEALIKAAPQS	123.62	gnl|BL_ORD_ID|1310|hsp_num:0	1428			117	735	
BGC0000225.1|Frenolicin_26 # 23106 # 23408 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.762	BGC0000225.1|Frenolicin_26 	23106	23408	-	Loose	525	23.0978	CRP-1	31.03	3006868	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CRP beta-lactamase	ATGATCAACCAGATGCTCCTGCACGGCGACGAGAGCCGTTTCCTCGCGGTCCTCGAAGAGATCTGCGCCCACATGCGCGCGCAGCCCGGCTTCCTCTCCCTGCGCCTGCACCGCTCGCCCGACCACCCCGAGCGGTGGGCCATGCTCGCCGACTGGAGCGACGCCGCCGCCCACCGGGCGGCGGCGAGCGCCCCCGGCATCCGGCCCGCCTTCGCGCGGCTGCGCGCCGAGGCCCACACCGCGCCGCAGGTCTACGCCCCGGTGCCCACGCCCGGCGCACCGGCCGGGGACTCCCTCGCCTGA	MINQMLLHGDESRFLAVLEEICAHMRAQPGFLSLRLHRSPDHPERWAMLADWSDAAAHRAAASAPGIRPAFARLRAEAHTAPQVYAPVPTPGAPAGDSLA	MRLSRRLVLLSCLLLPQAGFSAAMPANLADQKIARLERVFGGQIGVYALDTGSGAAVSYRADERFPLCSSFKGFLAASALAHSQSKPGFLDQILHYGKEELIAWSPISEKHQSSGMTVAGLCAATVQYSDNAAANVLMKQLDGPAGLTAFMRAIGDSTFRLDRWEPELNTAIPGDARDTSTPRAVAESLQKLTLGTALAAHQRQQLVDWLKGNTTGNQRIRAAVPAGWLVGDKTGTCGVYGTANDYAVIWPTGRAPIVMAVYTRASKKDIKHSDAVIADAAKAALEALGVMTR	34.13	gnl|BL_ORD_ID|3415|hsp_num:0	4484			240	327	
BGC0000225.1|Frenolicin_27 # 23613 # 25058 # -1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.685	BGC0000225.1|Frenolicin_27 	23613	25058	-	Loose	1700	28.8758	AxyY	21.54	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACTGTCAACGAGGACTCGTTCACCAACTGGAAGACCCGCGAGGAGATCGCGGAATCGATGATCCCCGTCATCGGCAGGCTCCAGCGGCAACGGGACGTCACCGTGCTGCTGCACAGCCGCTCGCTGGTGAACAAGTCGGTGGTCGGGATTCTCAAGACCCACCGATTCGCCCGGCAGATCGCGGGCGAGGAGCTGTCGGTCACCGAGACCATGCCGTTCCTCCAGGCGCTCACGACGCTCGACCTCGGCCCCTCCCAGATCGACATCGGCATGCTCGCCGAGACCTACAAGAGCGACGACCGGGGCCTGGGCGTCGCCGAGTTCACCGCGCGGCCCGTCGAGGGCGCGACCGGCGAGCGGAAGATCGAGCGCGCCGCCCCGCGCGACGTCGTCCTCTACGGCTTCGGGCGGATCGGGCGGCTCCTCGCCCGGCTGCTCATCGAGAAGGCCGGCTCGGGCAACGGCCTGCGTCTGCGCGCCGTCGTGGTCCGCAAGACCGCCGGTCAGGACCTCGTCAAGCGCGCCTCACTGCTGCGCCGCGACTCCGTGCACGGCCAGTTCCAGGGCACGATCATCGTGGACGAGGAGAACGACACCCTCATCGCGAACGGCAACGCGATCCGGTTCATCTACTCCGACGACCCGGCGACCGTGGACTACACCGCCTACGGCATCAACGACGCGATCCTCGTCGACAACACGGGCCGCTGGCGCGACCGCGCGGGCCTCTCGCAGCATCTGCGCCCGGGTGTCGCGAAGGTCGTCCTCACCGCGCCCGGCAAGGGCGACGTGCCGAACATCGTGCACGGCGTGAACCACGAGACGATCAAGCCGGACGAGCGGATCATCTCCTGCGCCTCCTGCACGACGAACGCCATCGTGCCGCCGCTCAAGGCGATGGCCGACGAGTTCGGCGTCGAGAGCGGCCACGTCGAGACGGTGCACTCCTTCACCAACGACCAGAACCTGCTGGACAATTACCACAAGTCCGACCGGCGAGGGCGGTCCGCGCCGCTCAACATGGTCCTCACCGAGACGGGTGCCGCCTCGGCCGTCGCGAAGGCTCTGCCGGACCTCGGGGCGAAGATCAGCGGCAGCTCGATCCGCGTTCCCGTCCCCGATGTGTCGATCGCGATCCTGAACCTCCGGCTGAGCCGCGGGACGAGCCGCGAGGAGGTCCTCACCCACCTGCGCGAGGTCTCCCTCACCTCGCCGCTGCGCCGCCAGATCGACTTCACCACCTCCGCCGACGCCGTCTCCAGCGACTTCGTCGGCTCGCGCCACGCCTCGATCGTGGACGCCGGGGCGACCAAGGTCGACGGCGACAACGCGATCCTCTACCTCTGGTACGACAACGAGTTCGGCTACTCGTGCCAGGTCGTACGGGTCGTCCAGCACGTCTCGGGCGTCGAGTACCCGACCTTCCCCGCACCGCTCGGCTGA	MTVNEDSFTNWKTREEIAESMIPVIGRLQRQRDVTVLLHSRSLVNKSVVGILKTHRFARQIAGEELSVTETMPFLQALTTLDLGPSQIDIGMLAETYKSDDRGLGVAEFTARPVEGATGERKIERAAPRDVVLYGFGRIGRLLARLLIEKAGSGNGLRLRAVVVRKTAGQDLVKRASLLRRDSVHGQFQGTIIVDEENDTLIANGNAIRFIYSDDPATVDYTAYGINDAILVDNTGRWRDRAGLSQHLRPGVAKVVLTAPGKGDVPNIVHGVNHETIKPDERIISCASCTTNAIVPPLKAMADEFGVESGHVETVHSFTNDQNLLDNYHKSDRRGRSAPLNMVLTETGAASAVAKALPDLGAKISGSSIRVPVPDVSIAILNLRLSRGTSREEVLTHLREVSLTSPLRRQIDFTTSADAVSSDFVGSRHASIVDAGATKVDGDNAILYLWYDNEFGYSCQVVRVVQHVSGVEYPTFPAPLG	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	46.03	gnl|BL_ORD_ID|2411|hsp_num:0	2799			1527	1917	erythromycin; cefepime
BGC0000225.1|Frenolicin_28 # 25055 # 25306 # -1 # ID=1_28;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000225.1|Frenolicin_28 	25055	25306	-	Loose	1000	23.0978	MCR-7.1	32.14	3004517	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GCCGCACGTTCCGCACCCGCACCGCACGTTCCGCACCTCGCCGCACGTTCCGCACCCGCACCGCACGTACTGCACCCCCGCCGCACGTCCCCCCACCGGCCACCCACACCCCGCACCCGGTGCTCCGCGCCCCCATCCCCGACGTCCCGCACCCGCCCCGAGCTGGTCGTACATCACACCCGCGCCCGGCAGATGATCACACCCATCGGGTTAACATATGAGCGCCGCCTAGCTCGAAAGATGGATCTGTGA	AARSAPAPHVPHLAARSAPAPHVLHPRRTSPHRPPTPRTRCSAPPSPTSRTRPELVVHHTRARQMITPIGLTYERRLARKMDL	MRITLGVMKVNLLLVLFFALVLNWPFFLRFYSVISGLEHVRAGFVISVPLVLLAALNAVFIPFTFRWLLKPFFSLLILTGSIVSYAMLKYGVIFDASMIQNIVETNNSEATSYLNVPVVLWFLLTGVLPMVVLWSLKVRYPANWYKGLAIRAGALAFSLLFVGGVAALYYQDYVSIGRNHRILGKQIVPANYVNGIYKYARDVVFATPIPYQPLGTDAKVVAKGDKPTLMFLVVGETARGKNFSMNGYEKETNPFTSQAGGVISFKDVRSCGTATAVSVPCMFSNMGRKEFDDNRARNSEGLLDVLQRSGVSIFWKENDGGCKGVCDRVPNIEIKPKDHPQFCDKNTCYDEVVLQNLDDEVAQMKGDKLVGFHLIGSHRPPYHQRYPDKPPPFVPDCPRSDIENCSDEELVNTYDNTIRYTDFVIAEMITKLKKYEDKYNTALIYLSDHGESLGAMGLYLHGTPYKFAPDDQTRVPMQVWMSPGFAKEKGMDLNCLQQKAADNRYSHDNLFSSVLGIWDVSTAVYDKQLDIFSQCRTVQ	15.40	gnl|BL_ORD_ID|2678|hsp_num:0	3145			1116	1200	colistin A; colistin B
